If you purchased certain kinds of cleaning products that were recalled by Colgate-Palmolive, you could be eligible to be part of a $1.9 million settlement. Certain Fabuloso brand cleaning products ...
The multipurpose cleaners may be contaminated with antibiotic-resistant bacteria By Althea Chang-Cook About 4.9 million bottles of Fabuloso multipurpose cleaners are being recalled due to possible ...
Check your Fabuloso bottles and tell your mami, papi, tía, tío, abuela and abuelo to check theirs, too. Colgate-Palmolive just recalled 4.9 million of them in the United States and another ...
In the preceding three months, 8 analysts have released ratings for Colgate-Palmolive CL, presenting a wide array of perspectives from bullish to bearish. In the table below, you'll find a summary ...
Opinions expressed by Forbes Contributors are their own. We see that P&G has demonstrated better revenue growth over the recent years, is more profitable, and offers a comparatively lower ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Colgate-Palmolive (NYSE:CL) declares $0.50/share quarterly dividend, 4.2% increase from prior dividend of $0.48. Forward yield 2.24% Payable May 15; for shareholders of record April 22; ex-div ...
At Colgate-Palmolive, we are really proud that Colgate is in more homes than any other, so we can and we will create a healthier, more sustainable future for all. Colgate Palmolive is tagged in 71 ...
According to GlobalData’s company profile on Colgate-Palmolive, Nanoemulsion cosmetics was a key innovation area identified from patents. Colgate-Palmolive's grant share as of January 2024 was 63%.
Colgate-Palmolive increased its quarterly common stock cash dividend 4% to 50 cents a share from 48 cents a share, effective in the second quarter. The new payout, equal to $2 a year, represents ...
In recent trading, shares of Colgate-Palmolive Co. (Symbol: CL) have crossed above the average analyst 12-month target price of $88.23, changing hands for $88.76/share. When a stock reaches the ...